TRIDENT LIFELINE
Back to Cashflow Statement
|
TRIDENT LIFELINE Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹20 Cr | ₹11 Cr | ₹42 Cr | ₹0.80 Cr |
What is the latest Cash Flow from Financing Activities ratio of TRIDENT LIFELINE ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹20 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹42 Cr |
| Mar2022 | ₹0.80 Cr |
How is Cash Flow from Financing Activities of TRIDENT LIFELINE Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹20 Cr | 79.51 | |
| Mar2024 | ₹11 Cr | -73.97 | |
| Mar2023 | ₹42 Cr | 5,172.19 | |
| Mar2022 | ₹0.80 Cr | - | |
Compare Cash Flow from Financing Activities of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹295.8 Cr | 2.3% | -6.7% | -6.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,620.0 Cr | 1% | -0.9% | 6.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,087.0 Cr | 1.8% | -2.3% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹154,837.0 Cr | 3.7% | 6.5% | 44.9% | Stock Analytics | |
| CIPLA | ₹112,194.0 Cr | 0% | 4.7% | -8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,328.0 Cr | -0.2% | 0.7% | -3.4% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | 2.3% |
-6.7% |
-6.2% |
| SENSEX | 1.7% |
1.3% |
-7.3% |
You may also like the below Video Courses